The global equine health market reached approximately $2.5 billion in 2025, anchored by the U.S. (~$1B), Europe, and the Middle East as the largest markets. Boehringer Ingelheim leads with ZIMETA, EQUIOXX, and the Equine Influenza vaccine franchise. Zoetis, Merck Animal Health, and Vetoquinol compete across vaccines, anti-inflammatories, and reproduction. Performance medicine — joint health, respiratory therapy, and regenerative medicine — represents the highest-growth sub-segment driven by sport horse and racing economies in Kentucky, Dubai, and Hong Kong.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Topics Covered
• Equine Health Market Size, Growth and Forecast 2025-2030
• Equine Vaccines — Influenza, West Nile, Rhinopneumonitis, Tetanus
• Anti-Inflammatories and Pain Management — EQUIOXX, ZIMETA, Bute
• Reproduction and Fertility Therapeutics
• Joint Health and Lameness Therapeutics
• Respiratory Therapeutics and Performance Medicine
• Regenerative Medicine — PRP, Stem Cell, IRAP
• Equine Diagnostics and Imaging
• Sport Horse and Racing Industry Economics
• Regional Markets — U.S., Europe, Middle East, Asia-Pacific
Table of Contents
1. Executive Summary
2. Market Overview
3. Equine Health Market Size, Growth and Forecast 2025-2030
4. Equine Vaccines
5. Anti-Inflammatories and Pain Management
6. Reproduction and Fertility
7. Joint Health and Lameness
8. Respiratory and Performance Medicine
9. Regenerative Medicine
10. Equine Diagnostics and Imaging
11. Sport Horse and Racing Economics
12. Regional Markets
13. Market Challenges and Risks
14. Competitive Landscape
15. Strategic Conclusions and Recommendations
16. Appendix
List of Tables
Table 1. Equine Health Market Size and Forecast 2025-2030
Table 2. Equine Vaccine Sales by Indication and Supplier
Table 3. Anti-Inflammatory Sales — EQUIOXX, ZIMETA, Bute
Table 4. Reproduction and Fertility Therapeutics Market
Table 5. Joint Health Therapeutics Sales by Supplier
Table 6. Regenerative Medicine Adoption by Practice
Table 7. Equine Diagnostic Volume by Modality
Table 8. Sport Horse and Racing Industry Spending by Region
Table 9. Equine Health M&A Activity 2023-2026
Table 10. Competitive Positioning by Therapeutic Category
Companies Profiled
Boehringer Ingelheim Animal Health
Ceva Santé Animale
Dechra Pharmaceuticals
Elanco Animal Health
Merck Animal Health
Vetoquinol
Virbac
Zoetis
